Literature DB >> 6779655

The retina in Lafora disease: light and electron microscopy.

M Berard-Badier, J F Pellissier, D Gambarelli, T de Barsy, J Roger, M Toga.   

Abstract

Lafora bodies are described in the retina of a 16 year old female who died five years after the onset of a typical familial progressive myoclonus epilepsy which was diagnosed as Lafora disease by brain biopsy and by autopsy findings. The patient was the offspring of consanguinous parents who had three affected siblings out of nine. The fine structure and distribution of Lafora bodies, which represent a specific non-lysosomal cell storage disorder, is reported for the first time in the human retina. The nature of the abnormal material in the Lafora bodies, which are identical to those present in the brain, heart and liver tissues in the same patient and in her brother, is discussed according to their iodide spectrum. In this respect, Lafora disease might be related to the inborn errors of carbohydrate metabolism and its relationship with Type IV Glycogenosis (Anderson's disease) must be verified by further investigations.

Entities:  

Mesh:

Year:  1980        PMID: 6779655     DOI: 10.1007/bf00410522

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  19 in total

1.  THE RETINAL PATHOLOGY OF LAFORA'S DISEASE: A FORM OF GLYCOPROTEIN-ACID MUCOPOLYSACCHARIDE DYSTROPHY.

Authors:  M YANOFF; G A SCHWARZ
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1965 Jul-Aug

2.  Retinal architecture and pathophysiology.

Authors:  D G COGAN
Journal:  Am J Ophthalmol       Date:  1962-09       Impact factor: 5.258

3.  Progressive familial myoclonic epilepsy in three families: its clinical features and pathological basis.

Authors:  D G HARRIMAN; J H MILLAR; A C STEVENSON
Journal:  Brain       Date:  1955-09       Impact factor: 13.501

4.  [Neuropathology of encephalopathies caused by inborn errors of lipid, carbohydrate and amino metabolism].

Authors:  J F Pellissier; M Bérard-Badier; D Gambarelli; J Hassoun; M F Tripier; M Toga
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1978 Jan-Mar

5.  Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.

Authors:  S Yokoi; J Austin; F Witmer; M Sakai
Journal:  Arch Neurol       Date:  1968-07

6.  [Histochemical studies on myoclonus bodies in progressive myoclonus epilepsy (Unverricht type)].

Authors:  R Schnabel; F Seitelberger
Journal:  Acta Neuropathol       Date:  1969-09-09       Impact factor: 17.088

7.  [Ultrastructure of Lafora bodies].

Authors:  M Toga; D Dubois; J Hassoun
Journal:  Acta Neuropathol       Date:  1968-03-04       Impact factor: 17.088

8.  Lafora's disease in the dog. A comparative study.

Authors:  J M Holland; W C Davis; D J Prieur; G H Collins
Journal:  Am J Pathol       Date:  1970-03       Impact factor: 4.307

9.  [Progressive myoclonus epilepsy with Lafora bodies. (Clinical, polygraphic and anatomic study of a case)].

Authors:  J Roger; H Gastaut; M Toga; R Soulayrol; H Régis; H Lob; A Tassinari; D Dubois; Y Poinso; E Mesdjian
Journal:  Rev Neurol (Paris)       Date:  1965-01       Impact factor: 2.607

10.  [Progressive myoclonus epilepsy with Lafora bodies. Clinical and polygraphic study. Anatomical ultrastructural verification].

Authors:  J Roger; H Gastaut; J Boudouresques; M Toga; D Dubois; H Lob
Journal:  Rev Neurol (Paris)       Date:  1967-03       Impact factor: 2.607

View more
  7 in total

Review 1.  Lacritin and other autophagy associated proteins in ocular surface health.

Authors:  Roy Karnati; Venu Talla; Katherine Peterson; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

2.  Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

Authors:  M Kathryn Brewer; Annette Uittenbogaard; Grant L Austin; Dyann M Segvich; Anna DePaoli-Roach; Peter J Roach; John J McCarthy; Zoe R Simmons; Jason A Brandon; Zhengqiu Zhou; Jill Zeller; Lyndsay E A Young; Ramon C Sun; James R Pauly; Nadine M Aziz; Bradley L Hodges; Tracy R McKnight; Dustin D Armstrong; Matthew S Gentry
Journal:  Cell Metab       Date:  2019-07-25       Impact factor: 27.287

3.  Polyglucosan body structure in Lafora disease.

Authors:  M Kathryn Brewer; Jean-Luc Putaux; Alberto Rondon; Annette Uittenbogaard; Mitchell A Sullivan; Matthew S Gentry
Journal:  Carbohydr Polym       Date:  2020-04-14       Impact factor: 9.381

4.  Polyglucosan bodies in intramuscular motor nerves.

Authors:  R A Bernsen; H L Busard; H J Ter Laak; F J Gabreëls; W O Renier; E M Joosten; A G Theeuwes
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Ocular phenotype and electroretinogram abnormalities in Lafora disease: A "window to the brain".

Authors:  Ajoy Vincent; Angelo Macrì; Anupreet Tumber; Nikolas Koukas; Saija Ahonen; Pasquale Striano; Berge Minassian
Journal:  Neurology       Date:  2018-06-15       Impact factor: 9.910

6.  Lafora disease as a cause of visually exacerbated myoclonic attacks in a dog.

Authors:  Aubrey A Webb; Chantal McMillan; Cheryl L Cullen; Sarah E Boston; Julie Turnbull; Berge A Minassian
Journal:  Can Vet J       Date:  2009-09       Impact factor: 1.008

7.  Retinal alterations in patients with Lafora disease.

Authors:  Heather Heitkotter; Rachel E Linderman; Jenna A Cava; Erica N Woertz; Rebecca R Mastey; Phyllis Summerfelt; Toco Y Chui; Richard B Rosen; Emily J Patterson; Ajoy Vincent; Joseph Carroll; Berge A Minassian
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.